NISHITH.TV
  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York

Locations

  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York
  • Content
  • Home
  • ABOUT US
  • NDA in the Media
  • Areas of Service
  • Research and Articles
  • Opportunities
  • Contact
  • NDACloud
  • Client Access
  • Member Access
  • Events and Calender
  • How we perform
  • Knowledge anywhere, anytime
  • See our recent deals
  • Up to date legal developments
  • Case studies in M&A

Research and Articles


  • Research at NDA
  • Research Papers
  • Research Articles
  • NDA Think Tanks
  • NDA Hotline
  • New Ali Gunjan
  • Japan Desk ジャパンデスク

NDA-Hotline


  • Capital Markets Hotline
  • Companies Act Series
  • Climate Change Related Legal Issues
  • Competition Law Hotline
  • Corpsec Hotline
  • Court Corner
  • Cross Examination
  • Deal Destination
  • Debt Funding in India Series
  • Dispute Resolution Hotline
  • Education Sector Hotline
  • FEMA Hotline
  • Financial Service Update
  • Food & Beverages Hotline
  • Funds Hotline
  • Gaming Law Wrap
  • GIFT City Express
  • Green Hotline
  • HR Law Hotline
  • iCe Hotline
  • Insolvency and Bankruptcy Hotline
  • International Trade Hotlines
  • Investment Funds: Monthly Digest
  • IP Hotline
  • IP Lab
  • Legal Update
  • Lit Corner
  • M&A Disputes Series
  • M&A Hotline
  • M&A Interactive
  • Media Hotline
  • New Publication
  • Other Hotline
  • Pharma & Healthcare Update
  • Private Client Wrap
  • Private Debt Hotline
  • Private Equity Corner
  • Real Estate Update
  • Realty Check
  • Regulatory Digest
  • Regulatory Hotline
  • Renewable Corner
  • SEZ Hotline
  • Social Sector Hotline
  • Tax Hotline
  • Technology & Tax Series
  • Technology Law Analysis
  • Telecom Hotline
  • The Startups Series
  • White Collar and Investigations Practice
  • Yes, Governance Matters.
  • Japan Desk ジャパンデスク

Pharma & Healthcare Update

1234
TITLE 
DATE 
First Exclusive Marketing Rights granted to Indian Pharmaceutical Company
09-25-2003
Should Phase 1 Trials be permitted in India? - Debate continues
11-15-2003
In Pipeline: New Drug policy
08-12-2005
Destination India: Fastest growing Asian hub for clinical trials
10-14-2005
New Bill to regulate scientific research on humans
12-15-2005
Guidelines for Medical Devices notified as "Drugs"
03-02-2006
Recent Mumbai High Court Rulings on Drug Regulations
05-11-2006
Mashelkar Committee submits its report on patentability of NCE's and micro-organisms
01-18-2007
Government contemplating to allow Phase I trials in India
08-09-2007
Novartis' Challenge To Section 3(d) Of Patents Act Dismissed
08-10-2007
Patentee to be heard in proceedings for compulsory licensing for export
07-08-2008
Pay To Participants For Research Related Injuries- Suggests ICMR
11-26-2008
Clinical Trials - Added Stringent Measures On Their Way!
04-22-2009
Phase I trials for drugs discovered outside India take a backseat yet again
05-15-2009
Revised Mashelkar Committee Report on Patent Law Issues accepted by the Government
08-25-2009
The noose tightens around adulterated and spurious drugs players
08-27-2009
Probiotic foods market in India soon to be regulated
12-26-2009
Indian drug authorities to now visit and inspect foreign manufacturers' facilities
01-14-2011
Pharma Regulatory Update 2010
02-08-2011
Clinical Trial Related Information Exempted from Disclosure
06-16-2011

Mission and Vision


Distinctly Different

What's New


AIF participation in Credit Default Swaps
Funds Hotline: January 20,2023
SEBI's Comprehensive Framework on Offer for Sale Through Stock Exchanges
Corpsec Hotline : January 20,2023

Events


Webinars

Foreign Higher Educational Institutions' Route to India: Discussing UGC's Draft Regulations
January 27,2023 - January 27,2023

Seminar

Evolution of White collar crimes and Investigations
January 31,2023 - January 31,2023

Round Table

Investing In Net Zero
July 22,2022 - July 22,2022

This event is over. For event material please click here

News Roundup


News Articles

Shareholder Activism: An ESG tool or a Founder’s curse?
October 13,2022

Quotes

Air India employees penalised with pay-cut; hopes pinned on HCTold double the market rent will be deducted from salary until they vacate AI properties
January 11,2023

Newsletters


Funds Hotline

AIF participation in Credit Default Swaps
January 20,2023

Corpsec Hotline

SEBI's Comprehensive Framework on Offer for Sale Through Stock Exchanges
January 20,2023

Dispute Resolution Hotline

A New Composite Approach: Singapore Court of Appeal settles law for determining arbitrability of disputes
January 19,2023

  • Disclaimer
  • Content
  • Feedback
  • Walkthrough
  • Subscribe
Nishith Desai Associates@2016 All rights reserved.